CONTACT-02 Trial Results: Cabozantinib and Atezolizumab in Metastatic Prostate Cancer The combination of cabozantinib (Cabometyx) and atezolizumab (Tecentriq) reduced the risk of disease progression or death by approximately 35% in …
Tag:
traitement
-
-
Cancer and cardiovascular diseases remain the leading causes of death in France, together accounting for nearly half of all mortality, according to the latest data from Santé publique France and …
-
Hantavirus Vaccine Development: Progress Following the MV Hondius Outbreak A recent outbreak of hantavirus aboard the cruise ship MV Hondius has brought a rare and dangerous pathogen back into the …